Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Halperin

Showing results (451-460 of 544) with videos related to

Pageof 55
Sort By:
Cell|January 27, 2007
Small-molecule inhibition of the interaction between the translation initiation factors eIF4E and eIF4GNathan J Moerke, Huseyin Aktas, Han Chen, et al.
Diabetes Care|April 29, 2017
Plasma Glycated CD59, a Novel Biomarker for Detection of Pregnancy-Induced Glucose IntolerancePamela Ghosh, Miguel A Luque-Fernandez, Anand Vaidya, et al.
Vaccine|August 2, 2011
Tolerability and antibody response in adolescents and adults revaccinated with tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine adsorbed (Tdap) 4-5 years after a previous doseScott A Halperin, Shelly McNeil, Joanne Langley, et al.
Journal of the Pediatric Infectious Diseases Society|February 26, 2014
Comparison of the Safety and Immunogenicity of a Novel Quadrivalent Meningococcal ACWY-Tetanus Toxoid Conjugate Vaccine and a Marketed Quadrivalent Meningococcal ACWY-Diphtheria Toxoid Conjugate Vaccine in Healthy Individuals 10-25 Years of AgeScott A Halperin, Yaela Baine, Joseph B Domachowske, et al.
The Journal of Infection|January 29, 2018
Functional activity of maternal and cord antibodies elicited by an investigational group B Streptococcus trivalent glycoconjugate vaccine in pregnant womenMonica Fabbrini, Fabio Rigat, Giovanna Tuscano, et al.
Pediatrics|July 20, 2011
Randomized controlled trial of dose response to influenza vaccine in children aged 6 to 23 monthsDanuta M Skowronski, Travis S Hottes, Mei Chong, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|May 18, 2018
Canadian vaccine research networks: Vaccine safety resources for CanadaJ McCarthy, S A Halperin, J A Bettinger, et al.
Plos One|September 9, 2025
Gaps in immunization coverage at school entry and after two years of school attendance among immigrant and refugee children in Ontario, CanadaSarah E Wilson, Catharine Chambers, Andrew S Wilton, et al.
Vaccine|October 2, 2021
Factors affecting antibody responses to immunizations in infants born to women immunized against pertussis in pregnancy and unimmunized women: Individual-Participant Data Meta-analysisBahaa Abu-Raya, Kirsten Maertens, Flor M Munoz, et al.
Clinical and Vaccine Immunology : CVI|May 24, 2013
Elevated inflammatory mediators in adults with oculorespiratory syndrome following influenza immunization: a public health agency of Canada/Canadian Institutes of Health Research Influenza Research Network StudyMona Al-Dabbagh, Keswadee Lapphra, David W Scheifele, et al.
Pageof 55

Showing results (451-460 of 544) with videos related to

Sort By:
Pageof 55
Cell|January 27, 2007
Small-molecule inhibition of the interaction between the translation initiation factors eIF4E and eIF4GNathan J Moerke, Huseyin Aktas, Han Chen, et al.
Diabetes Care|April 29, 2017
Plasma Glycated CD59, a Novel Biomarker for Detection of Pregnancy-Induced Glucose IntolerancePamela Ghosh, Miguel A Luque-Fernandez, Anand Vaidya, et al.
Vaccine|August 2, 2011
Tolerability and antibody response in adolescents and adults revaccinated with tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine adsorbed (Tdap) 4-5 years after a previous doseScott A Halperin, Shelly McNeil, Joanne Langley, et al.
Journal of the Pediatric Infectious Diseases Society|February 26, 2014
Comparison of the Safety and Immunogenicity of a Novel Quadrivalent Meningococcal ACWY-Tetanus Toxoid Conjugate Vaccine and a Marketed Quadrivalent Meningococcal ACWY-Diphtheria Toxoid Conjugate Vaccine in Healthy Individuals 10-25 Years of AgeScott A Halperin, Yaela Baine, Joseph B Domachowske, et al.
The Journal of Infection|January 29, 2018
Functional activity of maternal and cord antibodies elicited by an investigational group B Streptococcus trivalent glycoconjugate vaccine in pregnant womenMonica Fabbrini, Fabio Rigat, Giovanna Tuscano, et al.
Pediatrics|July 20, 2011
Randomized controlled trial of dose response to influenza vaccine in children aged 6 to 23 monthsDanuta M Skowronski, Travis S Hottes, Mei Chong, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|May 18, 2018
Canadian vaccine research networks: Vaccine safety resources for CanadaJ McCarthy, S A Halperin, J A Bettinger, et al.
Plos One|September 9, 2025
Gaps in immunization coverage at school entry and after two years of school attendance among immigrant and refugee children in Ontario, CanadaSarah E Wilson, Catharine Chambers, Andrew S Wilton, et al.
Vaccine|October 2, 2021
Factors affecting antibody responses to immunizations in infants born to women immunized against pertussis in pregnancy and unimmunized women: Individual-Participant Data Meta-analysisBahaa Abu-Raya, Kirsten Maertens, Flor M Munoz, et al.
Clinical and Vaccine Immunology : CVI|May 24, 2013
Elevated inflammatory mediators in adults with oculorespiratory syndrome following influenza immunization: a public health agency of Canada/Canadian Institutes of Health Research Influenza Research Network StudyMona Al-Dabbagh, Keswadee Lapphra, David W Scheifele, et al.
Pageof 55